Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Bernard Leick, M.D.

Concepts (124)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunotherapy, Adoptive24202413932.620 Why?
Receptors, Antigen, T-Cell7202425110.970 Why?
Hematologic Neoplasms4202218370.930 Why?
Graft vs Host Disease3202229320.920 Why?
Pulmonary Alveolar Proteinosis12022400.810 Why?
Hematopoietic Stem Cell Transplantation4202354570.690 Why?
Hematologic Diseases220234930.690 Why?
Communication Barriers120204110.570 Why?
Professional-Family Relations120204880.540 Why?
Leukemia, Myeloid, Acute3202235410.520 Why?
Lymphoma, B-Cell120209250.460 Why?
fms-Like Tyrosine Kinase 3120174920.450 Why?
T-Lymphocytes172024100190.430 Why?
Neurotoxicity Syndromes220232940.310 Why?
Lymphohistiocytosis, Hemophagocytic220232610.300 Why?
Physician-Patient Relations1202032030.290 Why?
Communication1202037930.270 Why?
Glioblastoma4202434620.270 Why?
Molecular Targeted Therapy1201727830.260 Why?
Interleukin-7120231400.220 Why?
Transplantation Conditioning2202015660.220 Why?
B-Cell Maturation Antigen120241480.210 Why?
GPI-Linked Proteins120244630.210 Why?
Central Nervous System Neoplasms220228900.210 Why?
Lymphoma2202218760.190 Why?
Xenograft Model Antitumor Assays3202435290.190 Why?
Protein Kinase Inhibitors1201756130.180 Why?
Endopeptidases120247750.180 Why?
Interleukin 1 Receptor Antagonist Protein120222990.180 Why?
Hospital Departments120201360.180 Why?
Translating120201500.160 Why?
Antineoplastic Agents22023135840.160 Why?
Pancytopenia120191010.160 Why?
Humans3620247468390.150 Why?
Cyclophosphamide2202322000.150 Why?
Lentivirus120204950.150 Why?
Transduction, Genetic120208950.150 Why?
Lymphoma, T-Cell, Cutaneous120192090.150 Why?
Proto-Oncogene Proteins c-bcl-21202414080.150 Why?
Neoplasms32023217160.140 Why?
Telephone120206190.140 Why?
Antigen-Presenting Cells120209440.140 Why?
Antibodies, Bispecific120191820.140 Why?
Tandem Repeat Sequences120171820.140 Why?
Multiple Myeloma2202450960.130 Why?
Sulfonamides1202419560.120 Why?
Ubiquitin-Protein Ligases1202318550.120 Why?
Lymphoma, Non-Hodgkin1202113790.110 Why?
Autoantibodies1202220440.110 Why?
Gene Expression Regulation, Leukemic120176470.110 Why?
Drug Approval120208100.110 Why?
Flow Cytometry1202458430.110 Why?
Biological Products120228840.110 Why?
Lymphoma, Large B-Cell, Diffuse1202213930.100 Why?
United States Food and Drug Administration1202016540.100 Why?
Bone Marrow Transplantation1201926780.100 Why?
Tumor Microenvironment1202436950.100 Why?
Antigens, Neoplasm1201919750.100 Why?
Organoplatinum Compounds120124020.090 Why?
Hodgkin Disease1201913780.090 Why?
Antigens, CD19220224090.080 Why?
Apoptosis1202494470.080 Why?
Intensive Care Units1202036740.070 Why?
Cell Line, Tumor42024166680.070 Why?
Pancreatic Neoplasms1202452600.070 Why?
Skin1201943900.070 Why?
Neoplasm Staging12020110780.070 Why?
Antibodies, Monoclonal1202391070.070 Why?
Combined Modality Therapy1201785210.060 Why?
Antineoplastic Combined Chemotherapy Protocols22017115850.060 Why?
Disease Progression12020133190.060 Why?
Cytokines3202372390.050 Why?
bcl-X Protein120244210.050 Why?
Drug Resistance, Neoplasm1201751670.050 Why?
France120235000.050 Why?
Clinical Trials as Topic1201779420.050 Why?
Antibodies, Viral2202230740.050 Why?
Transgenes1202410050.050 Why?
Ubiquitination120239950.040 Why?
Macrophage Activation120225500.040 Why?
Serine Endopeptidases1202410200.040 Why?
Mice52024802640.040 Why?
Codon, Nonsense120192790.040 Why?
Brain Neoplasms1201988570.040 Why?
Liver Neoplasms1201242540.040 Why?
Cell Death1202216660.030 Why?
United States22023704740.030 Why?
Transforming Growth Factor beta1202319580.030 Why?
Leukocytes, Mononuclear1202218240.030 Why?
Adult520232152880.030 Why?
Neoplasm Recurrence, Local2202491930.030 Why?
Child22023785200.030 Why?
Fatal Outcome1201918240.030 Why?
Exanthema120195000.030 Why?
Treatment Outcome22019637670.030 Why?
Neoplasms, Experimental1201912290.030 Why?
Signal Transduction12017231550.030 Why?
Retrospective Studies22019783600.030 Why?
Animals520241665780.030 Why?
Interferon-gamma1202231440.030 Why?
Carcinoma, Pancreatic Ductal1202416720.030 Why?
Mutation12017296370.030 Why?
Infusions, Intra-Arterial120122210.030 Why?
Fever1201916040.030 Why?
Proto-Oncogene Proteins1202444860.020 Why?
Peptide Fragments1202450360.020 Why?
Hepatic Artery120122300.020 Why?
CD8-Positive T-Lymphocytes1202445160.020 Why?
Vaccination1202232830.020 Why?
Bone Marrow1201929040.020 Why?
Biopsy1201967340.020 Why?
Membrane Proteins1202477880.020 Why?
Adenocarcinoma1202463000.020 Why?
Aged420221644570.020 Why?
Cognition1202367850.020 Why?
Incidence12023208210.020 Why?
Middle Aged420222146980.020 Why?
Diagnosis, Differential12019128420.010 Why?
Cell Differentiation12019113870.010 Why?
Male420223515380.010 Why?
Female320223825650.010 Why?
Young Adult12019572150.010 Why?
Adolescent12019863240.010 Why?
Aged, 80 and over12012576220.000 Why?
Leick's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (124)
Explore
_
Co-Authors (74)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.